ATRA vs COP
Atara Biotherapeutics Inc (ATRA) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
ATRA currently screens at market cap $87.1M. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the ATRA and COP stock pages for the full models.
Not investment advice.